Quantbot Technologies LP Edgewise Therapeutics, Inc. Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$9.25 - $19.97 $56,277 - $121,497	6,084 Added 316.05%	8,009 $146,000
Q4 2023 Feb 14, 2024	SELL	$5.51 - $12.1 $4,270 - $9,377	-775 Reduced 28.7%	1,925 $21,000
Q3 2023 Nov 07, 2023	BUY	$5.73 - $7.69 $15,471 - $20,763	2,700 New	2,700 $15,000
Q3 2022 Nov 07, 2022	BUY	$8.08 - $13.58 $4,040 - $6,790	500 Added 62.5%	1,300 $12,000
Q1 2022 May 16, 2022	BUY	$9.1 - $18.97 $7,280 - $15,176	800 New	800 $7,000

189

100M

2.17M

410K

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.76B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.